Related Experiment Video
Updated: Aug 8, 2026

In Vitro Analysis of Myd88-mediated Cellular Immune Response to West Nile Virus Mutant Strain Infection
Published on: November 27, 2014
Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal
Sateesh Krishnamurthy1, Toru Takimoto, Ruth Ann Scroggs
1Department of Infectious Diseases, Mail Stop 330, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105-2794, USA.
Abstract:
Newcastle disease virus (NDV) is a negative-strand RNA virus with oncolytic activity against human tumors. Its effectiveness against tumors and safety in normal tissue have been demonstrated in several clinical studies. Here we show that the spread of NDV infection is drastically different in normal cell lines than in tumor cell lines and that the two cell types respond differently to beta interferon (IFN-beta) treatment. NDV rapidly replicated and killed HT-1080 human fibrosarcoma cells but spread poorly in CCD-1122Sk human skin fibroblast cells. Pretreatment with endogenous or exogenous IFN-beta completely inhibited NDV replication in normal cells but had little or no effect in tumor cells. Thus, the outcome of NDV infection appeared to depend on the response of uninfected cells to IFN-beta. To investigate their differences in IFN responsiveness, we analyzed and compared the expression and activation of components of the IFN signal transduction pathway in these two types of cells. The levels of phosphorylated STAT1 and STAT2 and that of the ISGF3 complex were markedly reduced in IFN-beta-treated tumor cells. Moreover, cDNA microarray analysis revealed significantly fewer IFN-regulated genes in the HT-1080 cells than in the CDD-1122Sk cells. This finding suggests that tumor cells demonstrate a less-than-optimum antiviral response because of a lesion in their IFN signal transduction pathway. The rapid spread of NDV in HT-1080 cells appears to be caused by their deficient expression of anti-NDV proteins upon exposure to IFN-beta.
Insights
Newcastle disease virus (NDV) shows different infection patterns in normal versus tumor cells. Tumor cells exhibit a weaker antiviral response to interferon-beta (IFN-beta), enabling rapid NDV spread.
Area of Science:
- Virology
- Oncolytic Viruses
- Immunology
Background:
- Newcastle disease virus (NDV) is a negative-strand RNA virus with demonstrated oncolytic activity against human tumors.
- Clinical studies show NDV's effectiveness against tumors and safety in normal tissues.
- Differences in NDV infection spread and cellular response to interferon-beta (IFN-beta) between normal and tumor cells are observed.
Purpose of the Study:
- To investigate the differential response of normal and tumor cells to NDV infection and IFN-beta treatment.
- To compare the IFN signal transduction pathway in normal versus tumor cells.
- To elucidate the mechanisms behind NDV's differential spread and replication.
Main Methods:
- Comparative analysis of NDV replication and spread in HT-1080 (tumor) and CCD-1122Sk (normal) cell lines.
- Assessment of NDV replication inhibition by IFN-beta in both cell types.
- Analysis of IFN signal transduction pathway components (phosphorylated STAT1/STAT2, ISGF3 complex) via Western blot or similar techniques.
- Gene expression profiling using cDNA microarrays to compare IFN-regulated genes.
Main Results:
- NDV replicated rapidly and killed HT-1080 cells, but spread poorly in CCD-1122Sk cells.
- IFN-beta pretreatment completely inhibited NDV replication in normal cells but had minimal effect on tumor cells.
- Tumor cells showed reduced levels of phosphorylated STAT1, STAT2, and the ISGF3 complex upon IFN-beta treatment.
- Fewer IFN-regulated genes were identified in tumor cells compared to normal cells, indicating a deficient antiviral response.
Conclusions:
- Tumor cells possess a deficient IFN signal transduction pathway, leading to a less-than-optimum antiviral response.
- The impaired IFN response in tumor cells allows for the rapid spread of NDV.
- The differential response to IFN-beta is a key factor determining the outcome of NDV infection in normal versus tumor cells.

